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In view of their prevalence and their high 
socioeconomic importance for sufferers 
and for the healthcare system, allergies 
are today rightly characterised as a wide-
spread disease [1].
The prevalence of allergies has in-
creased dramatically in many regions of 
the world in recent years, without any ex-
act explanatory model having been found 
for this increase. The rising prevalence of 
allergies is generally seen as being asso-
ciated with various aspects of our “West-
ern lifestyle” [2]. Evidence was found to 
support this hypothesis in Germany fol-
lowing reunification. In the German states 
that made up the former East Germany, 
the frequency of allergic diseases was con-
siderably lower than in West Germany de-
spite the higher air pollution levels [3, 4]. 
The prevalence of allergies in East and 
West Germany has converged as lifestyles 
in the two regions have become more sim-
ilar [5].
Views have differed on the trend in al-
lergy prevalence in Germany since the 
strong increase that was observed be-
tween the early 1970s and the early 1990s. 
While some of the literature suggests that 
prevalence might have reached a plateau 
[6], other authors appear to predict a fur-
ther increase [7].
None of the said studies had the chance 
to observe the frequency of allergic dis-
eases on the basis of a highly representa-
tive population sample. The evaluation of 
the findings of the German Health Inter-
view and Examination Survey for Adults 
(DEGS1) and comparison with the data 
from the German National Health Inter-
view and Examination Survey 1998 (GN-
HIES98) form the basis for estimates of al-
lergy prevalence in the resident German 
adult population and permit the charting 
of a trend in prevalence for the last decade.
Methods
The “German Health Interview and Ex-
amination Survey for Adults” (DEGS) is 
part of the health monitoring system at 
the Robert Koch Institute (RKI). The con-
cept and design of DEGS are described in 
detail elsewhere [8, 9, 10, 11, 12]. The first 
wave (DEGS1) was conducted from 2008 
to 2011 and comprised interviews, exami-
nations and tests [13, 14]. The target popu-
lation comprises the residents of Germany 
aged 18–79 years. DEGS1 has a mixed de-
sign that permits both cross-sectional and 
longitudinal analyses. For this purpose, a 
random sample from local population 
registries was drawn to complete the par-
ticipants of the “German National Health 
Interview and Examination Survey 1998” 
(GNHIES98) who re-participated. A to-
tal of 8,152 persons participated, includ-
ing 4,193 first-time participants (response 
rate 42%) and 3,959 revisiting participants 
of GNHIES98 (response rate 62%). In all, 
7,238 persons attended one of the 180 ex-
amination centres, and 914 were inter-
viewed only. The net sample (n=7,988) 
permits representative cross-sectional and 
time-trend analyses to be performed for 
the age range of 18–79 years in compar-
ison with GNHIES98 (n=7,124) [9]. The 
data of the revisiting participants can be 
used for longitudinal analyses.
Both DEGS1 and GNHIES98 used stan-
dardised computer-assisted medical inter-
views (CAPI) to ask participants about the 
medically diagnosed occurrence of asthma, 
allergic rhinoconjunctivitis, contact ecze-
ma, atopic dermatitis, food allergies and 
urticaria. In addition, DEGS1 included a 
question on a medically diagnosed insect 
venom allergy. Affirmative responses to the 
question whether the participants had ever 
been medically diagnosed with one of the 
listed diseases contributed to the score for 
the lifetime prevalence of the respective dis-
ease. If participants said they had suffered 
from the disease during the 12 months be-
fore the survey (GNHIES98) or that they 
had been medically diagnosed with an al-
lergy in the last 12 months, this was listed as 
a positive 12-month prevalence for the dis-
ease in question. Details of the age, gender, 
socioeconomic status, region of residence 
(West/East Germany) and size of the mu-
nicipality of residence were collected using 
a self-administered questionnaire. Socio-
economic status was determined using an 
index that includes information on school 
education and vocational training, profes-
sional status and net household income 
(weighted by household needs) and which 
enables a classification into low-, middle- 
and high-status groups [15].
This article determined the age- and 
sex-stratified lifetime and 12-month 
prevalence with corresponding 95% con-
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18–29 30–39 40–49 50–59 60–69 70–79 Total
Disease Sex        
Asthma Women 12.8 (9.9–16.4) 9.4 (6.7–12.9) 11.7 (9.1–15.0) 7.5 (5.5–10.0) 10.4 (7.8–13.7) 7.0 (5.0–9.6) 9.9 (8.8–11.2)
Men 11.3 (8.3–15.1) 7.6 (5.1–11.3) 7.1 (5.1–9.9) 5.4 (3.7–7.8) 6.4 (4.5–9.0) 4.6 (3.0–6.9) 7.3 (6.2–8.6)





Women 19.0 (15.9–22.6) 22.7 (18.2–27.9) 19.1 (15.9–22.7) 14.1 (11.4–17.3) 13.0 (10.1–16.6) 9.7 (6.9–13.5) 16.5 (15.2–18.0)
Men 16.1 (12.5–20.4) 18.9 (15.2–23.4) 15.4 (12.7–18.7) 11.6 (9.2–14.6) 7.5 (5.6–9.8) 4.3 (2.9–6.5) 13.0 (11.7–14.4)
Total 17.5 (15.1–20.2) 20.8 (17.9–24.0) 17.2 (15.2–19.4) 12.9 (11.1–14.9) 10.3 (8.4–12.6) 7.3 (5.5–9.6) 14.8 (13.8–15.8)
Atopic 
dermatitis
Women 6.6 (4.8–9.1) 5.7 (3.8–8.3) 3.1 (2.0–4.7) 3.8 (2.6–5.5) 2.4 (1.5–3.9) 1.6 (0.7–3.3) 3.9 (3.3–4.6)
Men 6.3 (4.1–9.7) 2.7 (1.6–4.6) 4.0 (2.4–6.8) 1.7 (0.9–3.3) 1.1 (0.4–2.6) 0.9 (0.4–2.3) 3.1 (2.4–4.0)
Total 6.5 (5.0–8.4) 4.2 (3.0–5.9) 3.6 (2.5–5.0) 2.8 (2.0–3.9) 1.7 (1.1–2.7) 1.3 (0.7–2.3) 3.5 (3.0–4.1)
Urticaria Women 1.6 (0.7–3.7) 5.2 (3.2–8.3) 4.4 (3.1–6.2) 7.6 (5.6–10.2) 6.8 (4.8–9.4) 4.4 (2.9–6.6) 4.9 (4.1–5.9)
Men 1.3 (0.6–2.6) 1.3 (0.6–3.0) 3.0 (1.7–5.2) 1.9 (1.1–3.2) 2.8 (1.5–5.2) 1.3 (0.5–3.4) 2.0 (1.5–2.7)
Total 1.4 (0.8–2.5) 3.3 (2.1–4.9) 3.7 (2.7–5.0) 4.7 (3.6–6.2) 4.8 (3.7–6.4) 3.0 (2.0–4.4) 3.5 (3.0–4.0)
Contact 
eczema
Women 8.9 (6.3–12.5) 16.7 (13.4–20.7) 16.2 (13.5–19.4) 15.2 (12.4–18.5) 9.6 (7.3–12.5) 7.9 (5.5–11.3) 12.7 (11.5–14.0)
Men 2.7 (1.6–4.3) 4.1 (2.3–7.2) 5.2 (3.6–7.5) 1.9 (1.0–3.4) 3.5 (2.1–5.7) 3.0 (1.6–5.3) 3.4 (2.8–4.2)
Total 5.7 (4.2–7.6) 10.4 (8.3–12.9) 10.6 (9.0–12.5) 8.5 (7.0–10.4) 6.6 (5.2–8.4) 5.7 (4.2–7.8) 8.1 (7.3–8.9)
Food 
 allergy
Women 7.6 (5.4–10.6) 6.4 (4.1–9.9) 7.7 (5.5–10.7) 6.7 (4.9–9.0) 6.1 (4.2–9.0) 3.0 (1.8–5.0) 6.4 (5.5–7.5)
Men 4.3 (2.5–7.4) 3.0 (1.8–5.0) 4.3 (2.9–6.4) 2.0 (1.2–3.4) 1.3 (0.7–2.6) 1.4 (0.6–3.0) 2.9 (2.3–3.7)




Women 3.5 (2.0–5.9) 3.7 (2.2–6.3) 4.0 (2.6–6.1) 3.6 (2.4–5.2) 3.6 (2.3–5.4) 3.1 (1.9–5.1) 3.6 (2.9–4.4)
Men 2.1 (0.9–4.7) 1.5 (0.7–3.2) 2.7 (1.6–4.7) 2.1 (1.2–3.8) 2.1 (1.0–4.3) 0.8 (0.4–1.7) 2.0 (1.5–2.7)










27.0 (22.6–31.9) 29.4 (25.5–33.6) 20.8 (17.5–24.5) 19.7 (16.5–23.5) 14.3 (11.3–
17.9) 
24.1 (22.4–26.0)
Total 32.6 (29.6–35.7) 34.6 (30.9–38.4) 33.4 (30.9–36.0) 28.8 (25.9–31.8) 26.5 (23.7–29.6) 20.6 (17.8–
23.7)
30.0 (28.7–31.3)
In percent with 95% confidence intervals, statistically significant differences between the sexes are in bold type
nunweighted =7,988 aAt least one allergic disease was named
Tab. 2 Lifetime prevalence of at least one allergic disease (asthma, allergic rhinoconjunctivitis, atopic dermatitis, urticaria, contact eczema, food 

























































































In percent with 95% confidence intervals; statistically significant differences in the stated influencing factors are in bold type and those between women and men marked 
by an asterisk; nunweighted =7,988 inh. inhabitants
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fidence intervals (95% CI) of allergic dis-
eases and compared the figures with the 
GNHIES98 data. Data were evaluated 
using SPSS, Version 20 (SPSS Inc., Chi-
cago, IL, USA). A weighting factor was 
used in all analyses to take account of de-
viations in the sample from the popula-
tion structure (as of 31 December 2010) 
with regard to age, sex, region, nation-
ality, as well as community type and ed-
ucation [9]. A separate weighting factor 
was prepared for the examination part. 
Calculation of the weighting factor al-
so considered the re-participation prob-
ability of the  GNHIES98 participants 
based on a logistic regression model. For 
the purpose of conducting trend analy-
sis, the data from GNHIES98 were age-
adjusted to the population level as of 
31 December 2010. A non-response anal-
ysis and a comparison of selected indica-
tors with data from census statistics in-
dicate a high level of representativity of 
the net sample for the resident popula-
tion of Germany aged 18–79 years [9]. To 
take into account the weighting as well as 
the correlation of the participants with-
in a community, the confidence inter-
vals were determined with SPSS 20 pro-
cedures for complex samples. Differenc-
es were regarded as statistically signifi-
cant if the respective 95% confidence in-
tervals did not overlap.
Results
Allergic diseases in DEGS1: 
lifetime prevalence
The lifetime prevalence for the medical 
diagnosis of allergic diseases surveyed in 
DEGS1 was 8.6% for asthma, 14.8% for al-
lergic rhinoconjunctivitis, 3.5% for atop-
ic dermatitis and urticaria, 8.1% for con-
tact eczema, 4.7% for food allergies and 
2.8% for insect venom allergies. In all, 
30% of adults have been medically diag-
nosed as suffering from at least one of the 
afore-mentioned allergic diseases dur-
ing their lifetime (. Tab. 1). In general, a 
significantly higher percentage of women 
(35.8%) than men (24.1%) said they had 
been given at least one allergy diagnosis; 
9.9% versus 7.3% for asthma, for example, 
and 16.5% versus 13.0% for allergic rhino-
conjunctivitis (both differences are also 
significant). The difference between the 
sexes was particularly marked in the case 
of contact eczema, and this difference was 
significant in all age groups. Women and 
men between the ages of 18 and 49 years 
showed a higher prevalence for most al-
lergic diseases than the older age groups.
A statistically significant higher prev-
alence for at least one reported allergy 
diagnosis was seen for adults from West 
Germany and Berlin, women from large 
towns and adults with high socioeconom-
ic status than for adults from East Germa-
ny, women from small towns and adults 
with middle or low socioeconomic sta-
tus (. Tab. 2). One of the detailed find-
ings of our evaluation is that almost two 
in three of all 30–39-year-old women in 
Berlin (64.7%) said that they have been 
given a medical allergy diagnosis during 
the course of their life (data not shown in 
table).
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Abstract
In the first wave of the “German Health In-
terview and Examination Survey for Adults” 
(DEGS1), up-to-date and representative da-
ta regarding allergic diseases in 7,988 18- to 
79-year-old subjects living in Germany were 
collected using computer-assisted medi-
cal interviews. The study identified a lifetime 
prevalence of 8.6% for asthma, 14.8% for al-
lergic rhinoconjunctivitis, 3.5% each for atop-
ic dermatitis and urticaria, 8.1% for contact 
eczema, 4.7% for food allergies and 2.8% for 
insect venom allergies. Overall, nearly one 
third of adults in Germany have been diag-
nosed with at least one of the above-men-
tioned allergies during their lifetime by a phy-
sician. Currently, nearly 20% suffer from at 
least one allergic disease. Generally, women 
reported an allergic disease more frequently 
than men did and younger subjects more fre-
quently than older ones. Additionally, aller-
gies are more common in the former feder-
al states of West Germany than in the former 
East German federal states. A high socioeco-
nomic status and living in large cities both in-
crease allergy risk. During the last 10 years, 
asthma prevalence increased about 3%, 
whereas the prevalence of urticaria and con-
tact eczema declined. The lifetime prevalence 
of allergic rhinoconjunctivitis, atopic derma-
titis and food allergies appeared unchanged. 
In total, allergy prevalence has declined from 
32.7 to 28.7% over the past decade.
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Häufigkeit allergischer Erkrankungen in Deutschland. Ergebnisse 
der Studie zur Gesundheit Erwachsener in Deutschland (DEGS1)
Zusammenfassung
In der ersten Welle der „Studie zur Gesund-
heit Erwachsener in Deutschland“ (DEGS1) 
wurden aktuelle und bundesweit repräsen-
tative Daten zum allergischen Krankheits-
geschehen von 7988 18- bis 79-Jährigen mit-
tels computergestützter, ärztlicher Interviews 
erhoben. Demnach liegt die Lebenszeitpräva-
lenz (LZP) für Asthma bronchiale bei 8,6%, 
Heuschnupfen bei 14,8%, Neurodermitis und 
Urtikaria bei jeweils 3,5%, Kontaktekzeme bei 
8,1%, Nahrungsmittelallergien bei 4,7% und 
Insektengiftallergien bei 2,8%. Insge samt ist 
bei einem knappen Drittel der Er wachsenen 
mindestens eine der genannten Allergien je-
mals ärztlich diagnostiziert worden. Aktuell 
leiden fast 20% an mindestens einer Aller-
gie. Frauen sind generell häufiger betrof-
fen als Männer und Jüngere häufiger als Äl-
tere. Außerdem sind Allergien in den alten 
Bundesländern verbreiteter als in den neuen. 
Ein hoher sozioökonomischer Status und 
das Leben in Großstädten erhöhen ebenfalls 
die Krankheitshäufigkeit. Im 10-Jahres-Trend 
stieg die Asthmaprävalenz um knapp 3%, die 
Prävalenzen für Urtikaria und Kontaktekzeme 
sanken, die LZP für Heuschnupfen, Neuroder-
mitis und Nahrungsmittelallergie blieb un-
verändert. Dadurch ist die Allergieprävalenz 
insgesamt von 32,7% auf 28,7% rückläufig.
Schlüsselwörter
Allergische Erkrankungen ·  
Asthma bronchiale · Atopische  
Erkrankungen · Erwachsene ·  
Gesundheitssurvey
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Allergic diseases in DEGS1: 
12-month prevalence
During the 12 months before the sur-
vey, 5.0% of participants had medical-
ly diagnosed asthma, 12.0% allergic rhi-
noconjunctivitis, 2.2% atopic dermatitis, 
1.2% urticaria, 2.8% contact eczema, 2.5% 
food allergy and 0.5% insect venom al-
lergy. According to the survey, 19.4% of 
adults currently suffer from at least one 
allergic disease (. Tab. 3). Like lifetime 
prevalence, the 12-month prevalence for 
at least one allergic disease is signifi-
cantly higher among women than men 
(22.9% vs. 15.9%). In all, 6.3% of wom-
en currently suffer from asthma com-
pared to only 3.7% of men; the figures 
for allergic rhinoconjunctivitis are 13.3% 
for women compared to 10.6% for men, 
and these differences are also significant. 
A marked and significant difference be-
tween men and women was also found 
for contact eczema, particularly among 
the 40–59-year-olds. The 12-month prev-
alence of most allergies decreased with 
increasing age; this trend is significant 
from the age of 50 years with allergic rhi-
noconjunctivitis, for example.
Trend in allergic diseases over time
. Tab. 4 shows a comparison of the life-
time prevalence of various allergic dis-
eases between GNHIES98 and DEGS1. 
According to the figures, the preva-
lence of asthma has increased signifi-
cantly during the last 10 years, rising by 
just under three percentage points from 
5.7 to 8.6%; the increase is more marked 
among women than men. The differenc-
es were most significant in the age groups 
from 20 to 29 and 40 to 49 years. The 
prevalence of urticaria and contact ecze-
ma has fallen significantly over time, and 
this trend is primarily driven by young 
adults aged from 18 to 49 years and above 
all by the women in this age group. As 
with the lifetime prevalence of aller-
gic rhinoconjunctivitis, atopic dermati-
tis and food allergies in men and women 
in all age groups has remained constant 
over the last 10 years, while the overall 
prevalence for at least one reported al-
lergic disease has declined significantly 
(from 32.7 to 28.7%—. Tab. 4).




18–29 30–39 40–49 50–59 60–69 70–79 Total
Disease Sex        
Asthma Women 6.7 (4.6–9.5) 6.4 (4.3–9.6) 6.7 (4.7–9.6) 4.6 (3.0–6.8) 8.2 (5.9–11.4) 5.2 (3.5–7.7) 6.3 (5.4–7.3)
Men 4.0 (2.4–6.5) 4.6 (2.6–7.9) 3.4 (2.3–5.0) 3.1 (1.9–5.0) 4.5 (3.0–6.7) 2.3 (1.3–4.0) 3.7 (2.9–4.6)





Women 17.1 (14.0–20.7) 18.2 (14.4–22.8) 15.9 (12.9–19.4) 10.5 (8.2–13.3) 10.2 (7.7–13.3) 6.5 (4.3–9.6) 13.3 (12.1–14.6)
Men 12.2 (9.3–15.9) 16.2 (12.6–20.6) 12.9 (10.5–15.9) 9.7 (7.4–12.5) 6.1 (4.4–8.4) 3.1 (1.9–4.9) 10.6 (9.5–11.9)
Total 14.6 (12.4–17.1) 17.2 (14.6–20.2) 14.4 (12.5–16.5) 10.1 (8.5–11.9) 8.2 (6.5–10.3) 5.0 (3.6–6.8) 12.0 (11.1–12.9)
Atopic der-
matitis
Women 5.0 (3.5–7.1) 4.1 (2.6–6.5) 1.4 (0.8–2.7) 3.1 (2.0–4.9) 1.3 (0.7–2.4) 1.0 (0.4–2.6) 2.7 (2.2–3.3)
Men 3.7 (2.2–6.3) 1.0 (0.4–2.5) 2.5 (1.4–4.4) 1.0 (0.5–2.2) 0.9 (0.3–2.5) 0.5 (0.1–1.5) 1.8 (1.3–2.5)
Total 4.3 (3.2–5.9) 2.6 (1.7–3.8) 2.0 (1.3–3.0) 2.1 (1.4–3.0) 1.1 (0.7–1.9) 0.8 (0.4–1.6) 2.2 (1.9–2.7)
Urticaria Women 0.3 (0.1–1.2) 3.1 (1.6–6.1) 1.6 (0.9–2.9) 2.4 (1.5–3.8) 2.1 (1.2–3.5) 0.6 (0.3–1.5) 1.7 (1.3–2.3)
Men 0.7 (0.3–1.6) 0.6 (0.1–2.4) 0.9 (0.4–2.0) 1.1 (0.5–2.3) 0.8 (0.3–2.2) 0.3 (0.1–1.0) 0.8 (0.5–1.2)
Total 0.5 (0.2–1.0) 1.9 (1.0–3.4) 1.3 (0.8–2.0) 1.8 (1.2–2.6) 1.5 (0.9–2.3) 0.5 (0.2–1.0) 1.2 (1.0–1.6)
Contact 
eczema
Women 3.6 (2.1–6.0) 6.0 (3.8–9.3) 5.2 (3.6–7.5) 4.6 (3.0–6.8) 3.8 (2.5–5.6) 1.7 (0.8–3.5) 4.2 (3.5–5.0)
Men 1.0 (0.4–2.1) 1.7 (0.7–4.2) 2.0 (1.1–3.6) 1.4 (0.6–2.9) 2.0 (0.9–4.3) 0.4 (0.1–1.2) 1.5 (1.0–2.0)
Total 2.2 (1.4–3.5) 3.8 (2.5–5.8) 3.6 (2.6–4.8) 3.0 (2.1–4.2) 2.9 (2.0–4.2) 1.1 (0.6–2.1) 2.8 (2.4–3.3)
Food allergy Women 4.6 (2.9–7.1) 4.5 (2.6–7.8) 4.5 (2.9–6.9) 3.3 (2.2–5.0) 3.4 (1.9–6.0) 0.6 (0.3–1.4) 3.6 (2.9–4.5)
Men 1.8 (0.9–3.8) 1.5 (0.7–3.1) 2.4 (1.4–4.2) 1.3 (0.6–2.6) 0.5 (0.2–1.4) No case 1.4 (1.0–2.0)
Total 3.2 (2.2–4.6) 3.0 (1.9–4.7) 3.4 (2.4–4.9) 2.3 (1.6–3.3) 2.0 (1.2–3.4) 0.3 (0.2–0.8) 2.5 (2.1–3.0)
Insect ven-
om allergy
Women 0.7 (0.2–2.2) 1.1 (0.4–3.1) 0.9 (0.3–2.6) 0.7 (0.3–1.6) 0.4 (0.1–1.3) 0.1 (0.0–0.6) 0.7 (0.4–1.1)
Men 0.3 (0.0–1.8) 0.3 (0.1–1.3) 0.5 (0.1–1.9) 0.3 (0.1–1.0) No case 0.1 (0.0–0.5) 0.3 (0.1–0.6)
Total 0.5 (0.2–1.3) 0.7 (0.3–1.7) 0.7 (0.3–1.6) 0.5 (0.3–1.0) 0.2 (0.1–0.7) 0.1 (0.0–0.3) 0.5 (0.3–0.7)
Allergic dis-
easea











6.2 (4.5–8.5) 15.9 (14.3–17.5)




10.2 (8.2–12.7) 19.4 (18.3–20.5)
In percent with 95% confidence intervals; statistically significant differences between the sexes are in bold type












































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Allergic sensitisation is the topic of the ar-
ticle “Prevalence of sensitisation to aeroal-
lergens and food allergens—results of the 
German Health Interview and Examina-
tion Survey for Adults (DEGS1)”, also con-
tained in this issue.
Discussion
Method
In the DEGS1 survey, participants were 
asked by a physician about medically di-
agnosed allergies in a CAPI interview. 
This method ensures the collection of val-
id data and therefore forms the basis for 
a valid estimation of allergy prevalence 
[16]. In view of the fact that there may be 
no medical diagnosis despite the presence 
of an allergy—due, for example, to people 
suffering from only slight allergic symp-
toms not having seen a doctor—the prev-
alence estimates based on medical diag-
noses are conservative estimates. Howev-
er, comparison of answers to the two ques-
tions: “Have you ever suffered from …?” 
versus “Has a doctor ever diagnosed you 
with …?” showed over 90% correspon-
dence of the answers for allergic rhino-
conjunctivitis, food allergies and urticar-
ia and an approx. 80% correspondence 
for allergic contact eczema and asthma 
[4]. Moreover, the polling of medical di-
agnoses is a widespread and internation-
ally recognised method for the collection 
of data on allergies.
Lifetime prevalence
Almost one in three adults living in Ger-
many has at some point in their life been 
diagnosed with allergic disease. The pri-
mary forms of allergy are allergic rhino-
conjunctivitis, asthma and contact ecze-
ma. With the exception of atopic derma-
titis, all diagnosed allergies affect women 
significantly more frequently than men. 
One particularly conspicuous finding is 
the difference with regard to contact ec-
zema (12.7% women and 3.4% men). This 
difference is statistically significant across 
all age groups. One conceivable reason 
for this difference between the sexes is 
choice of occupation, another is the dif-
ference in frequency of contact with fash-
ion jewellery and perfumes. The “Allergy 
in Germany White Paper” [1], for exam-
ple, points to the fact that contact aller-
gies mainly take place via the hands and 
are in this respect often a manifestation 
of an occupational disease. The occupa-
tions that cause these allergies include fe-
male domains such as hairdressing, care 
or cleaning jobs. Nickel is still seen as the 
most frequent contact allergen—despite 
the fact that the amounts used in fashion 
jewellery are restricted—followed by per-
fumes.
There is a major discrepancy between 
the literature and the stated lifetime prev-
alence for medically diagnosed urticaria, 
which at 3.5% is well below the estimates 
of German associations that specialise in 
the field [1, 17]. It is possible that chron-
ic urticaria is more frequently remem-
bered by participants than the more com-
mon acute urticaria. The specialist bodies 
in Germany estimate that the prevalence 
of chronic urticaria in the general popula-
tion is about 2% [1].
The findings show that young adults 
suffer from atopic dermatitis consider-
ably more frequently than the older age 
groups. Atopic dermatitis is considered to 
be particularly common among children 
[18]. This means that the higher preva-
lence among young adults does not neces-
sarily indicate an increase in the frequen-
cy of the disease but could be due to mem-
ory bias. The shorter the time between the 
disease and the interview, the more often 
participants were able to recall the disease 
[19].
The difference in the frequency of al-
lergic illnesses between West and East 
Germany identified after the fall of the 
Berlin Wall remains significant, even 
though prevalence levels were expected 
to converge owing to the increased prev-
alence of allergies in East Germany [20] 
and although prevalence levels are indeed 
closer than they were. The manifestation 
of allergic diseases is seen as being closely 
connected to the Th1-Th2 differentiation 
of helper T cells in the immune system of 
children [21]. This means that improved 
hygiene and hence fewer infectious stimu-
li on the immune system create fewer Th1 
cells but more Th2 cells, which play a key 




















































































































































































































































































































































































































































































































































































































































es. It appears that the increased frequency 
of allergies among children due to chang-
es in living conditions has not been car-
ried over into the adult section of the pop-
ulation.
The shift in the Th1-Th2 balance is 
probably also responsible for the existing 
significant difference in allergy prevalence 
between small and large towns. The liter-
ature describes how children who have 
grown up on a farm are better protected 
against allergies [22, 23].
The phenomenon that allergic sensiti-
sation and therefore disease frequency in-
creases with rising socioeconomic status 
is well established among children and al-
so confirmed for adults by other German 
allergy studies like the KORA-C [24]. Our 
data underline this phenomenon among 
women more markedly than among men. 
The reasons for this are not known but are 
believed to be associated with the hygiene 
hypothesis (“exaggerated” hygiene among 
individuals of higher socioeconomic sta-
tus). One very recent hypothesis is based 
on a study [25] showing that the social 
ranking among monkeys is linked to gene 
regulatory variation, which in turn affects 
the immune cells. The decrease in T cells 
in the peripheral blood of animals of low 
social status correlated with increased 
probability of infections (although the hy-
giene hypothesis would suggest that these 
animals are less likely to suffer from aller-
gies).
Twelve-month prevalence
At 5.0%, the 12-month prevalence for 
asthma corresponds exactly to the prev-
alence estimate in the “Lung White Pa-
per” [26]. The higher disease frequency 
among women—in contrast to the higher 
prevalence among boys when it comes to 
children—is well established [27]. Wom-
en on the whole are also more likely to 
suffer from allergic rhinoconjunctivitis, a 
finding that has only been observed in the 
German health surveys conducted since 
1998 [28].
Atopic dermatitis is found far more fre-
quently in young adults than in older peo-
ple, and the 12-month prevalence of urti-
caria among women is double that among 
men; this is a disease that mainly affects 
women [1]. It is difficult to find an expla-
nation for this, since—as indicated by the 
figures for lifetime prevalence—the cur-
rent survey covers only some of the vari-
ous forms of urticaria. Women are in the 
majority for both the 12-month preva-
lence and lifetime prevalence of contact 
eczema, particularly so in the age groups 
in regular employment. Possible reasons 
for this have already been discussed in the 
section on lifetime prevalence.
Overall, women also report signifi-
cantly more frequently that they current-
ly suffer from food allergies, and the older 
age groups (60 years and above) are main-
ly responsible for the magnitude of this 
difference. One reason for this could be 
that women have a more varied diet than 
men [29] and therefore come into contact 
with a higher number of potential aller-
gens.
Overall, insect venom allergies are sel-
dom, even though their potentially seri-
ous effects on health mean they are of sci-
entific interest [30].
Trend over time
The sum of allergic diseases has decreased 
significantly since 1998, but a closer analy -
sis of the trends over time show that the 
prevalence of asthma has continued to in-
crease (in line with the trend observed be-
tween the 1970s and 1990s) and that the 
prevalence of allergic rhinoconjunctivitis, 
atopic dermatitis and food allergies has 
remained constant and has now reached 
a plateau. The visible decline in allergic 
diseases is driven by the lower incidence 
stated by participants of medical diagno-
ses for urticaria and contact eczema, par-
ticularly among the younger participants. 
One possible reason for this is that young-
er people really do suffer from these dis-
eases less frequently. There are, for exam-
ple, restrictions on highly allergenic sub-
stances in everyday objects, such as the 
use of nickel in fashion jewellery [31] or 
formaldehyde in cosmetics [32]. In addi-
tion, there is now broader public debate 
on the potential allergic effects of various 
substances, such as the use of henna or its 
additive p-phenylendiamine (PPD) as a 
hair dye or in reversible skin tattoos [33]. 
At the same time, there are other factors 
that may have resulted in a lower num-
ber of medical diagnoses despite an un-
changed prevalence of the disease itself. 
Ointments and creams containing cor-
ticosteroids are now available over the 
counter, for example [34], meaning that 
people can treat non-serious skin aller-
gies themselves and consult a doctor less 
often than they used to.
The increase in asthma remains an im-
portant issue, as this atopic disease is of 
high socioeconomic significance and rep-
resents a major burden for sufferers. An 
increase in prevalence was recently also 
reported among young adults (between 
the ages of 20 and 44 years) in Italy. The 
median prevalence of current asthma re-
corded in three Italian surveys rose from 
4.1% in 1991 to 6.6% in 2010 [35]. Accord-
ing to a study in the UK, the lifetime prev-
alence of asthma among adults increased 
by over 20% based on medical diagnoses 
between 2001 and 2005 [36].
The increase in asthma prevalence in 
DEGS1 is mainly attributed to the group 
of young adults. In the youngest age group 
from 18 to 29 years, it is the men who play 
the main role in this increase. Here again, 
this could be due to a number of factors: it 
is known—and confirmed by the data from 
the German Health Interview and Exam-
ination Survey for Children and Adoles-
cents (KiGGS)—that boys suffer more fre-
quently from asthma than girls do and that 
this trend is reversed around the time of pu-
berty [23, 37]. This reversal is seen as partly 
being due to the larger bronchial cross-sec-
tions among girls and men and partly due 
to hormonal factors. The task of follow-up 
studies will therefore be to establish wheth-
er the growth of the bronchial tubes of boys 
in puberty is less pronounced than it used 
to be (there is presently a downward trend 
in height increase in the USA [38]). The 
testosterone deficit evident today in men 
associated with overweight and chron-
ic disease, and that already manifests itself 
in younger years, has been described in the 
literature [39]. This could mean that hor-
monal protective factors are less present in 
men than they used to be. Moreover, since 
the symptoms of asthma are triggered by 
countless—and sometimes non-specific—
external stimuli, it will also be necessary to 
address the question of whether the more 
frequent use of cosmetics and perfume by 
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